Authors:
Jernstrom, H
Vesprini, D
Bradlow, HL
Narod, SA
Citation: H. Jernstrom et al., Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years, J NAT CANC, 93(7), 2001, pp. 554-555
Citation: Sa. Narod, Re: Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years, J NAT CANC, 93(5), 2001, pp. 396-396
Authors:
Jernstrom, H
Chu, M
Vesprini, D
Tao, YZ
Majeed, N
Deal, C
Pollak, M
Narod, SA
Citation: H. Jernstrom et al., Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk, MOL GEN MET, 72(2), 2001, pp. 144-154
Authors:
Jernstrom, H
Deal, C
Wilkin, F
Chu, W
Tao, YZ
Majeed, N
Hudson, T
Narod, SA
Pollak, M
Citation: H. Jernstrom et al., Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women, CANC EPID B, 10(4), 2001, pp. 377-384
Authors:
Runnebaum, IB
Wang-Gohrke, S
Vesprini, D
Kreienberg, R
Lynch, H
Moslehi, R
Ghadirian, P
Weber, B
Godwin, AK
Risch, H
Garber, J
Lerman, C
Olopade, OI
Foulkes, WD
Karlan, B
Warner, E
Rosen, B
Rebbeck, T
Tonin, P
Dube, MP
Kieback, DG
Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Authors:
Warner, E
Plewes, DB
Shumak, RS
Catzavelos, GC
Di Prospero, LS
Yaffe, MJ
Goel, V
Ramsay, E
Chart, PL
Cole, DEC
Taylor, GA
Cutrara, M
Samuels, TH
Murphy, JP
Murphy, JM
Narod, SA
Citation: E. Warner et al., Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer, J CL ONCOL, 19(15), 2001, pp. 3524-3531
Authors:
Narod, SA
Sun, P
Ghadirian, P
Lynch, H
Isaacs, C
Garber, J
Weber, B
Karlan, B
Fishman, D
Rosen, B
Tung, N
Neuhausen, SL
Citation: Sa. Narod et al., Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study, LANCET, 357(9267), 2001, pp. 1467-1470
Authors:
Nam, RK
Toi, A
Vesprini, D
Ho, M
Chu, W
Harvie, S
Sweet, J
Trachtenberg, J
Jewett, MAS
Narod, SA
Citation: Rk. Nam et al., V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression, UROLOGY, 57(1), 2001, pp. 199-204
Authors:
Bevan, S
Pal, T
Greenberg, CR
Green, H
Wixey, J
Bignell, G
Narod, SA
Foulkes, WD
Stratton, MR
Houlston, RS
Citation: S. Bevan et al., A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: Confirmation of linkage to TCO1, J CLIN END, 86(8), 2001, pp. 3701-3704
Authors:
Pal, T
Vogl, FD
Chappuis, PO
Tsang, R
Brierley, J
Renard, H
Sanders, K
Kantemiroff, T
Bagha, S
Goldgar, DE
Narod, SA
Foulkes, WD
Citation: T. Pal et al., Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: A hospital-based study, J CLIN END, 86(11), 2001, pp. 5307-5312
Authors:
Rebbeck, TR
Wang, YT
Kantoff, PW
Krithivas, K
Neuhausen, SL
Godwin, AK
Daly, MB
Narod, SA
Brunet, JS
Vesprini, D
Garber, JE
Lynch, HT
Weber, BL
Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Authors:
Risch, HA
McLaughlin, JR
Cole, DEC
Rosen, B
Bradley, L
Kwan, E
Jack, E
Vesprini, DJ
Kuperstein, G
Abrahamson, JLA
Fan, I
Wong, B
Narod, SA
Citation: Ha. Risch et al., Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer, AM J HU GEN, 68(3), 2001, pp. 700-710
Authors:
de los Rios, P
Jack, E
Kuperstein, G
Lynch, H
Lubinski, J
Narod, SA
Citation: P. De Los Rios et al., Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer, AM J HU GEN, 68(2), 2001, pp. 546-546
Authors:
Manning, AP
Abelovich, D
Ghadirian, P
Lambert, JA
Frappier, D
Provencher, D
Robidoux, A
Peretz, T
Narod, SA
Mes-Masson, AM
Foulkes, WD
Wang, TL
Morgan, K
Fujiwara, TM
Tonin, PN
Citation: Ap. Manning et al., Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families, HUMAN HERED, 52(2), 2001, pp. 116-120
Citation: Sa. Narod, Clinical characteristics of genetically determined breast cancer, MANAGEMENT OF PATIENTS AT HIGH RISK FOR BREAST CANCER, 2001, pp. 56-62
Authors:
Singh, R
Eeles, RA
Durocher, F
Simard, J
Edwards, S
Badzioch, M
Kote-Jarai, Z
Teare, D
Ford, D
Dearnaley, D
Ardern-Jones, A
Murkin, A
Dowe, A
Shearer, R
Kelly, J
Labrie, F
Easton, D
Narod, SA
Tonin, PN
Foulkes, WD
Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247
Authors:
Nam, RK
Diamandis, EP
Toi, A
Trachtenberg, J
Magklara, A
Scorilas, A
Papnastasiou, PA
Jewett, MAS
Narod, SA
Citation: Rk. Nam et al., Serum human glandular kallikrein-2 protease levels predict the presence ofprostate cancer among men with elevated prostate-specific antigen, J CL ONCOL, 18(5), 2000, pp. 1036-1042
Authors:
Chappuis, PO
Kapusta, L
Begin, LR
Wong, N
Brunet, JS
Narod, SA
Slingerland, J
Foulkes, WD
Citation: Po. Chappuis et al., Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer, J CL ONCOL, 18(24), 2000, pp. 4045-4052